Impact of the Novel 5-Group Cytogenetic Risk Classification of MDS on Outcome After Allogeneic Hematopoietic Cell Transplantation (HCT)

被引：3
|
作者：
Deeg, H. Joachim [1 ]
Scott, Bart Lee [1 ,2 ]
Appelbaum, Frederick R. [1 ]
Gooley, Ted [1 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[2] Univ Washington, Seattle, WA 98195 USA
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
10.1182/blood.V118.21.666.666
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：306 / 307
页数：2
相关论文
共 50 条
  • [31] Outcome and Mutational Profile in MDS Patients undergoing Allogeneic Hematopoietic Stem Cell Transplantation
    Tcvetkov, Nikolai
    Morozova, Elena
    Barkhatov, Ildar
    Moiseev, Ivan
    Barabanshikova, Maria
    Tishkov, Artem
    Bug, Dmitrij
    Izmailova, Ekaterina
    Bondarenko, Sergey
    Afanasyev, Boris
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 571 - 572
  • [32] Individual outcome prediction for myelodysplastic syndrome (MDS) and secondary acute myeloid leukemia from MDS after allogeneic hematopoietic cell transplantation
    Heuser, Michael
    Gabdoulline, Razif
    Loeffeld, Patrick
    Dobbernack, Vera
    Kreimeyer, Henriette
    Pankratz, Mira
    Flintrop, Madita
    Liebich, Alessandro
    Klesse, Sabrina
    Panagiota, Victoria
    Stadler, Michael
    Wichmann, Martin
    Shahswar, Rabia
    Platzbecker, Uwe
    Thiede, Christian
    Schroeder, Thomas
    Kobbe, Guido
    Geffers, Robert
    Schlegelberger, Brigitte
    Goehring, Gudrun
    Kreipe, Hans-Heinrich
    Germing, Ulrich
    Ganser, Arnold
    Kroeger, Nicolaus
    Koenecke, Christian
    Thol, Felicitas
    ANNALS OF HEMATOLOGY, 2017, 96 (08) : 1361 - 1372
  • [33] Individual outcome prediction for myelodysplastic syndrome (MDS) and secondary acute myeloid leukemia from MDS after allogeneic hematopoietic cell transplantation
    Michael Heuser
    Razif Gabdoulline
    Patrick Löffeld
    Vera Dobbernack
    Henriette Kreimeyer
    Mira Pankratz
    Madita Flintrop
    Alessandro Liebich
    Sabrina Klesse
    Victoria Panagiota
    Michael Stadler
    Martin Wichmann
    Rabia Shahswar
    Uwe Platzbecker
    Christian Thiede
    Thomas Schroeder
    Guido Kobbe
    Robert Geffers
    Brigitte Schlegelberger
    Gudrun Göhring
    Hans-Heinrich Kreipe
    Ulrich Germing
    Arnold Ganser
    Nicolaus Kröger
    Christian Koenecke
    Felicitas Thol
    Annals of Hematology, 2017, 96 : 1361 - 1372
  • [34] The Impact of Allogeneic Hematopoietic Cell Transplantation (HCT) and Treatment with Ruxolitinib on Survival in Patients with Myelofibrosis
    Jaekel, Nadja
    Wang, Song-Yau
    Krahl, Rainer
    Hubert, Karolin
    Schulze, Susann
    Stengel, Rayk
    Schneider, Melanie
    Roskos, Martin
    Niederwieser, Dietger
    Al-Ali, Haifa Kathrin
    BLOOD, 2015, 126 (23)
  • [35] Therapy-Related Myelodysplasia/Acute Myeloid Leukemia (t-MDS/AML) After Conventionally-Treated Breast Cancer: Impact of Cytogenetics on Outcome After Allogeneic Hematopoietic Cell Transplantation (HCT)
    Grover, Rahnder S.
    Pullarkat, Vinod
    Sun, Can-Lan
    Bhatia, Smita
    Forman, Stephen J.
    BLOOD, 2011, 118 (21) : 1774 - 1775
  • [36] Cytogenetic Evolution of Myeloid Neoplasms at Relapse after Allogeneic Hematopoietic Cell Transplantation
    Kelemen, Katalin
    Slack, James L.
    Khera, Nandita
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S155 - S155
  • [37] Factors influencing relapse after allogeneic hematopoietic cell transplantation (HCT) following reduced intensity conditioning (RIC) in patients with AML and MDS
    Al-Ali, Haifa K.
    Nehring, Claudia
    Krahl, Rainer
    Becker, Cornelia
    Leiblein, Sabine
    Edelman, Jeanett
    Poenisch, Wolfram
    Lange, Thoralf
    Niederwieser, Dietger
    BLOOD, 2007, 110 (11) : 493A - 493A
  • [38] Impact of T-cell depletion on outcome of patients undergoing allogeneic hematopoietic cell transplantation (HSCT) for myelodysplastic syndrome (MDS)
    Raboud, M.
    Beauverd, Y.
    Simonetta, F.
    Dantin, C.
    Pradier, A.
    Tsopra, O.
    Koutsi, A.
    Mamez, A-C
    Stephan, C.
    Morales, J. F. Rodriguez
    Polchlopeck-Blasiak, K.
    Tirefort, Y.
    Masouridi-Levrat, S.
    Chalandon, Y.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S478 - S478
  • [39] Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
    Sorror, ML
    Maris, MB
    Storb, R
    Baron, F
    Sandmaier, BM
    Maloney, DG
    Storer, B
    BLOOD, 2005, 106 (08) : 2912 - 2919
  • [40] Defining Successful Immune Reconstitution (IR) after Allogeneic Hematopoietic Cell Transplantation (HCT)
    Abu Shanap, Mayada Salman
    Cooley, Sarah
    Luo, Xianghua
    Qing, Cao
    Curtsinger, Julie
    Bergerson, Rachel
    Bejanyan, Nelli
    Stefanski, Heather
    Brunstein, Claudio
    Weisdorf, Daniel J.
    Blazar, Bruce R.
    Miller, Jeffrey S.
    Wagner, John E.
    Verneris, Michael R.
    BLOOD, 2015, 126 (23)
12345